Changeflow GovPing Healthcare & Life Sciences Antimicrobial Compositions Patent Application
Routine Notice Added Draft

Antimicrobial Compositions Patent Application

Email

Summary

The USPTO has published a patent application (US20260083126A1) for antimicrobial compositions containing organosulfur compounds. The application, filed on September 8, 2023, describes compounds useful for treating microbial infections and for cleaning, disinfecting, or agricultural use.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application filed with the USPTO, specifically application number US20260083126A1, titled 'Antimicrobial Compositions'. The application details organosulfur compounds such as Bis(4-fluorophenyl) disulfide and related thiosulfinates and thiosulfonates. These compounds are presented as useful for treating bacterial, fungal, protozoan, or algal infections, and also for cleaning, disinfecting, or agricultural applications.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, companies in the pharmaceutical, food manufacturing, or agricultural sectors may wish to review the disclosed compositions for potential licensing, research and development, or competitive intelligence purposes. The application was filed on September 8, 2023, and published with a projected application date of March 26, 2026.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

ANTIMICROBIAL COMPOSITIONS

Application US20260083126A1 Kind: A1 Mar 26, 2026

Inventors

Lex DE BOER, Petrus Hendricus NIBBERING, Anna Kristina WRONSKA, Shaista Sheroze KHOKHAR

Abstract

The disclosure relates to organosulfur compounds and compositions comprising same. In particular, the disclosure relates to Bis(4-fluorophenyl) disulfide, Bis(4-chlorophenyl) disulfide, Bis(4-chlorophenyl) thiosulfinate, Bis(4-fluorophenyl) thiosulfinate, Bis(4-chlorophenyl) thiosulfonate, Bis(4-fluorophenyl) thiosulfonate, and Di-isopropyl thiosulfonate. Such compositions are useful for treating microbial infection, in particular bacterial, fungal, rotozoan or algal infection. Compositions comprising said compounds are also provided for cleaning, disinfecting or agricultural use.

CPC Classifications

A01N 41/12 A01P 1/00 A61K 31/10 A61L 2/18 A61L 2103/05 A61P 31/04 A61L 2101/32 A61L 2103/15

Filing Date

2023-09-08

Application No.

19109833

View original document →

Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083126A1

Who this affects

Applies to
Drug manufacturers Food manufacturers Agricultural firms
Industry sector
3254 Pharmaceutical Manufacturing 3114 Food & Beverage Manufacturing
Activity scope
Drug Labeling Product Safety
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Food Safety Environmental Protection

Get alerts for this source

We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!